Centene
CNC • NYSE
Centene is a medical - healthcare plans company in the healthcare sector trading on NYSE, led by CEO Sarah London, with a market cap of $15.7B.
CEOSarah London
Next Earnings
Upcoming earnings announcement for Centene
Date
Friday, April 24, 2026 (in 3 weeks)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$2.03
Revenue Estimate
$47.5B
Earnings History
Past 12 earnings reports for Centene
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Q4 2025 | -$1.19Est: -$1.23 | +3.3% | $49.7BEst: $48.3B | +2.9% |  10-K |
| Oct 29, 2025 | Q3 2025 | $0.50Est: -$0.18 | +377.8% | $49.7BEst: $47.7B | +4.1% | 10-Q |
| Jul 25, 2025 | Q2 2025 | -$0.16Est: $0.41 | -139.0% | $48.7BEst: $44.1B | +10.5% | 10-Q |
| Apr 25, 2025 | Q1 2025 | $2.90Est: $2.54 | +14.2% | $46.6BEst: $43.4B | +7.5% | 10-Q |
| Feb 4, 2025 | Q4 2024 | $0.80Est: $0.49 | +63.3% | $40.8BEst: $39.3B | +3.8% | 10-K |
| Oct 25, 2024 | Q3 2024 | $1.62Est: $1.38 | +17.4% | $42.0BEst: $37.6B | +11.8% | 10-Q |
| Jul 26, 2024 | Q2 2024 | $2.42Est: $2.07 | +16.9% | $39.8BEst: $36.5B | +9.3% | 10-Q |
| Apr 26, 2024 | Q1 2024 | $2.26Est: $2.08 | +8.7% | $40.4BEst: $36.5B | +10.6% | 10-Q |
| Feb 6, 2024 | Q4 2023 | $0.45Est: $0.43 | +4.7% | $39.5BEst: $36.1B | +9.2% | 10-K |
| Oct 24, 2023 | Q3 2023 | $2.00Est: $1.57 | +27.4% | $38.0BEst: $36.2B | +5.1% | 10-Q |
| Jul 28, 2023 | Q2 2023 | $2.10Est: $2.05 | +2.4% | $37.6BEst: $36.0B | +4.4% | — |
| Apr 25, 2023 | Q1 2023 | $2.11Est: $2.10 | +0.5% | $38.9BEst: $36.0B | +8.2% | — |